Cargando…
Human models for COVID‐19 research
Currently, therapeutics for COVID‐19 are limited. To overcome this, it is important that we use physiologically relevant models to reproduce the pathology of infection and evaluate the efficacy of antiviral drugs. Models of airway infection, including the use of a human infection challenge model or...
Autores principales: | Woodall, Maximillian N. J., Masonou, Tereza, Case, Katie‐Marie, Smith, Claire M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447334/ https://www.ncbi.nlm.nih.gov/pubmed/34287894 http://dx.doi.org/10.1113/JP281499 |
Ejemplares similares
-
The social threats of COVID-19 for people with chronic pain
por: Karos, Kai, et al.
Publicado: (2020) -
Darmkrebsvorsorge zu COVID‑19‑Zeiten
por: Riemann, Jürgen F.
Publicado: (2021) -
Digital health in electrophysiology and the COVID-19 global pandemic
por: Slotwiner, David J., et al.
Publicado: (2020) -
COVID-19 vaccination in patients with long QT syndrome
por: Wu, Cheng-I., et al.
Publicado: (2022) -
COVID-19 pandemic in Panama: lessons of the unique risks and research opportunities for Latin America
por: Loaiza, Jose R., et al.
Publicado: (2020)